2015-21014. Notice Pursuant to the National Cooperative Research and Production Act of 1993-Pistoia Alliance, Inc.

Notice is hereby given that, on July 15, 2015, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (“the Act”), Pistoia Alliance, Inc. has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, DNAnexus, Mountain View, CA; Millennium Pharmaceuticals, Inc. a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA; Tessella, Abingdon, UNITED KINGDOM; and Vermillion Life Sciences Ltd., Colleyland, UNITED KINGDOM, have been added as parties to this venture.

Also, Etzard Stotle (individual member), Arlesheim, SWITZERLAND, has withdrawn as a party to this venture.

No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and Pistoia Alliance, Inc. intends to file additional written notifications disclosing all changes in membership.

On May 28, 2009, Pistoia Alliance, Inc. filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on July 15, 2009 (74 FR 34364).

The last notification was filed with the Department on April 29, 2015. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on June 4, 2015 (80 FR 31920).

Patricia A. Brink,

Director of Civil Enforcement, Antitrust Division.